Wednesday, February 3, 2016

Xarelto Lawsuit Says Blood Thinner Caused Gastrointestinal Bleed

Closeup patient's hand show blood transfusion in hostpitalA new Xarelto lawsuit was recently filed alleging that Janssen Pharmaceuticals violated consumer protection laws and put consumers at risk of suffering from dangerous gastrointestinal bleeds.

The Xarelto lawsuit was brought by multiple plaintiffs against the Xarelto makers. One plaintiff, Theresa B. of New York, states she began taking Xarelto in January of 2012 after she was prescribed the medication by her doctor.

Theresa continued taking the medication until March 2012 when she began to experience a gastrointestinal bleed and discontinued the medication. The Xarelto lawsuit alleges that Teresa’s gastrointestinal bleed was a direct result of taking the blood thinner.

The Xarelto lawsuit alleges that the plaintiffs, including Theresa, suffered serious physical pain and suffering and incurred significant medical expenses. The plaintiffs are attempting to hold the drug manufacturers responsible for the injuries, pain, and suffering the drug caused them.

Xarelto and the other new anticoagulant medications on the market often credit themselves as being superior to the older blood thinning medications like warfarin. The Xarelto lawsuit brought by Theresa challenges these declarations.

According to the Xarelto lawsuit, a study known as the Rocket AF study compared warfarin to Xarelto and found the latter superior. But the lawsuit alleges the study was poorly managed. Theresa claims that the poor management of the project made Xarelto appear superior to warfarin. In the lawsuit, Dr. Steven Nissen stated his concern that the dosages for the trial study were picked for advertising purposes rather than scientific data.

What is Xarelto?

Xarelto is a popular anticoagulant sold on the market. The medication was manufactured, advertised, and distributed in order to treat people who are at risk for stroke and systemic embolism in patients who suffer from atrial fibrillation. Xarelto is also prescribed to treat deep vein thrombosis and pulmonary embolism in patients who have recently undergone hip or knee replacement surgeries.

Xarelto was introduced to the US market back in 2011. Xarelto and many of the other newer oral anticoagulants are often referred to as the next generation of blood thinners. The older blood thinners on the market, such as warfarin, require patients to undergo constant blood monitoring and a strict diet. According to Xarelto’s marketing, the blood thinning medication does not require patients to follow those same restrictions.

Xarelto Side Effects

Numerous FDA adverse event reports have been filed regarding Xarelto side effects although all blood thinning medications pose the risk of uncontrolled bleeding. In the first quarter of 2012, the FDA received over 120 Xarelto bleeding reports with patients, like Teresa, reportedly suffering from gastrointestinal bleeds, hemorrhaging, and several other serious internal bleeding complications.

The Xarelto Lawsuit is part of the Xarelto MDL known as In re: Xarelto (Rivaroxaban) Products Liability Litigation, MDL 2592, in the U.S. District Court for the Eastern District of Louisiana.

Do YOU have a legal claim? Fill out the form on this page now for a free, immediate, and confidential case evaluation. The Xarelto attorneys who work with Top Class Actions will contact you if you qualify to let you know if an individual lawsuit or Xarelto class action lawsuit is best for you. [In general, Xarelto lawsuits are filed individually by each plaintiff and are not class actions.] Hurry — statutes of limitations may apply.

Learn More

Get Help – It’s Free

Join a Free Xarelto Class Action Lawsuit Investigation

If you or a loved one took Xarelto (rivaroxaban) and suffered injuries such as uncontrollable internal bleeding, gastrointestinal bleeding, hemorrhaging, deep vein thrombosis or pulmonary embolism, you may have a legal claim. See if you qualify by filling out the short form below.

An attorney will contact you if you qualify to discuss the details of your potential case at no charge to you.

  • First Name*
  • Last Name*
  • Street Address*
  • Apt. #
  • City*
  • State*
    AlabamaAlaskaArizonaArkansasCaliforniaColoradoConnecticutDelawareDistrict of ColumbiaFloridaGeorgiaHawaiiIdahoIllinoisIndianaIowaKansasKentuckyLouisianaMaineMarylandMassachusettsMichiganMinnesotaMississippiMissouriMontanaNebraskaNevadaNew HampshireNew JerseyNew MexicoNew YorkNorth CarolinaNorth DakotaOhioOklahomaOregonPennsylvaniaRhode IslandSouth CarolinaSouth DakotaTennesseeTexasUtahVermontVirginiaWashingtonWest VirginiaWisconsinWyomingArmed Forces AmericasArmed Forces EuropeArmed Forces Pacific
  • Zip Code*
  • Phone*
  • Email*
  • Which blood thinner did you or a loved one take at the time of the injury or injuries?*
    • Pradaxa
    • Xarelto
    • Unknown
    • Other
  • Please check the injuries suffered:*
    • Death

    • Gastrointestinal Bleeding

    • Other Internal Bleeding

    • Cerebral Hemorrhaging

    • Ischemic Stroke

    • Unsure

    • None

  • ¿Necesita un orador español?
    • Yes
    • No
  • Please enter any additional details you would like the staff reviewing your submission to know.*
  • I understand and agree that submitting this form does not create an attorney-client relationship and that the information I submit is not confidential or privileged and may be shared.*
    • Yes

if(typeof gf_global == ‘undefined’) var gf_global = {“gf_currency_config”:{“name”:”U.S. Dollar”,”symbol_left”:”$”,”symbol_right”:””,”symbol_padding”:””,”thousand_separator”:”,”,”decimal_separator”:”.”,”decimals”:2},”base_url”:”http:\/\/topclassactions.com\/wp-content\/plugins\/gravityforms”,”number_formats”:[],”spinnerUrl”:”http:\/\/topclassactions.com\/wp-content\/plugins\/gravityforms\/images\/spinner.gif”};jQuery(document).bind(‘gform_post_render’, function(event, formId, currentPage){if(formId == 35) {gformInitChosenFields(‘#input_35_5′,’No results matched’);if(!/(android)/i.test(navigator.userAgent)){jQuery(‘#input_35_7’).mask(‘(999) 999-9999’).bind(‘keypress’, function(e){if(e.which == 13){jQuery(this).blur();} } );}} } );jQuery(document).bind(‘gform_post_conditional_logic’, function(event, formId, fields, isInit){gformInitChosenFields(‘#input_35_5′,’No results matched’);} ); jQuery(document).ready(function(){jQuery(document).trigger(‘gform_post_render’, [35, 1]) } );

We tell you about cash you can claim EVERY WEEK! Sign up for our free newsletter.

  • Email*
  • State*
    selectAlabamaAlaskaArizonaArkansasCaliforniaColoradoConnecticutDelawareDistrict of ColumbiaFloridaGeorgiaHawaiiIdahoIllinoisIndianaIowaKansasKentuckyLouisianaMaineMarylandMassachusettsMichiganMinnesotaMississippiMissouriMontanaNebraskaNevadaNew HampshireNew JerseyNew MexicoNew YorkNorth CarolinaNorth DakotaOhioOklahomaOregonPennsylvaniaRhode IslandSouth CarolinaSouth DakotaTennesseeTexasUtahVermontVirginiaWashingtonWest VirginiaWisconsinWyomingArmed Forces AmericasArmed Forces EuropeArmed Forces Pacific


jQuery(document).ready(function($){gformInitSpinner( 5, ‘http://11284-presscdn-0-40.pagely.netdna-cdn.com/wp-content/plugins/gravityforms/images/spinner.gif’ );jQuery(‘#gform_ajax_frame_5’).load( function(){var contents = jQuery(this).contents().find(‘*’).html();var is_postback = contents.indexOf(‘GF_AJAX_POSTBACK’) >= 0;if(!is_postback){return;}var form_content = jQuery(this).contents().find(‘#gform_wrapper_5’);var is_confirmation = jQuery(this).contents().find(‘#gform_confirmation_wrapper_5’).length > 0;var is_redirect = contents.indexOf(‘gformRedirect(){‘) >= 0;var is_form = form_content.length > 0 && ! is_redirect && ! is_confirmation;if(is_form){jQuery(‘#gform_wrapper_5’).html(form_content.html());setTimeout( function() { /* delay the scroll by 50 milliseconds to fix a bug in chrome */ jQuery(document).scrollTop(jQuery(‘#gform_wrapper_5’).offset().top); }, 50 );if(window[‘gformInitDatepicker’]) {gformInitDatepicker();}if(window[‘gformInitPriceFields’]) {gformInitPriceFields();}var current_page = jQuery(‘#gform_source_page_number_5’).val();gformInitSpinner( 5, ‘http://11284-presscdn-0-40.pagely.netdna-cdn.com/wp-content/plugins/gravityforms/images/spinner.gif’ );jQuery(document).trigger(‘gform_page_loaded’, [5, current_page]);window[‘gf_submitting_5’] = false;}else if(!is_redirect){var confirmation_content = jQuery(this).contents().find(‘#gforms_confirmation_message_5’).html();if(!confirmation_content){confirmation_content = contents;}setTimeout(function(){jQuery(‘#gform_wrapper_5’).replaceWith(” + confirmation_content + ”);jQuery(document).scrollTop(jQuery(‘#gforms_confirmation_message_5’).offset().top);jQuery(document).trigger(‘gform_confirmation_loaded’, [5]);window[‘gf_submitting_5’] = false;}, 50);}else{jQuery(‘#gform_5’).append(contents);if(window[‘gformRedirect’]) {gformRedirect();}}jQuery(document).trigger(‘gform_post_render’, [5, current_page]);} );} ); if(typeof gf_global == ‘undefined’) var gf_global = {“gf_currency_config”:{“name”:”U.S. Dollar”,”symbol_left”:”$”,”symbol_right”:””,”symbol_padding”:””,”thousand_separator”:”,”,”decimal_separator”:”.”,”decimals”:2},”base_url”:”http:\/\/topclassactions.com\/wp-content\/plugins\/gravityforms”,”number_formats”:[],”spinnerUrl”:”http:\/\/topclassactions.com\/wp-content\/plugins\/gravityforms\/images\/spinner.gif”};jQuery(document).bind(‘gform_post_render’, function(event, formId, currentPage){if(formId == 5) {gformInitChosenFields(‘#input_5_2′,’No results matched’);} } );jQuery(document).bind(‘gform_post_conditional_logic’, function(event, formId, fields, isInit){gformInitChosenFields(‘#input_5_2′,’No results matched’);} ); jQuery(document).ready(function(){jQuery(document).trigger(‘gform_post_render’, [5, 1]) } );

The post Xarelto Lawsuit Says Blood Thinner Caused Gastrointestinal Bleed appeared first on Top Class Actions.

from http://topclassactions.com/lawsuit-settlements/lawsuit-news/306866-ny-woman-files-xarelto-lawsuit-gastrointestinal-bleed/


No comments:

Post a Comment